HomeABOS • NASDAQ
add
Acumen Pharmaceuticals Inc
Previous close
$2.70
Day range
$2.59 - $2.78
Year range
$1.81 - $11.31
Market cap
158.61M USD
Avg Volume
250.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.16M | 26.97% |
Net income | -14.87M | -31.54% |
Net profit margin | — | — |
Earnings per share | -0.25 | 10.71% |
EBITDA | -17.76M | -35.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 252.51M | 79.84% |
Total assets | 300.97M | 60.20% |
Total liabilities | 38.93M | 343.48% |
Total equity | 262.03M | — |
Shares outstanding | 60.08M | — |
Price to book | 0.62 | — |
Return on assets | -14.54% | — |
Return on capital | -15.05% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -14.87M | -31.54% |
Cash from operations | -17.86M | -75.52% |
Cash from investing | -9.20M | 78.05% |
Cash from financing | 7.11M | — |
Net change in cash | -19.96M | 61.70% |
Free cash flow | -13.20M | -98.11% |
About
Founded
Jan 1, 1996
Headquarters
Website
Employees
51